[go: up one dir, main page]

NO961685D0 - Fremgangsmåte for behandling av hepatitt-B-bærere med minimal sykdom - Google Patents

Fremgangsmåte for behandling av hepatitt-B-bærere med minimal sykdom

Info

Publication number
NO961685D0
NO961685D0 NO961685A NO961685A NO961685D0 NO 961685 D0 NO961685 D0 NO 961685D0 NO 961685 A NO961685 A NO 961685A NO 961685 A NO961685 A NO 961685A NO 961685 D0 NO961685 D0 NO 961685D0
Authority
NO
Norway
Prior art keywords
carriers
treating hepatitis
minimal disease
minimal
disease
Prior art date
Application number
NO961685A
Other languages
English (en)
Other versions
NO961685L (no
Inventor
Bruce F Scharschmidt
John D Baxter
David L Horwitz
Original Assignee
Sciclone Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/833,468 external-priority patent/US5308833A/en
Application filed by Sciclone Pharmaceuticals filed Critical Sciclone Pharmaceuticals
Publication of NO961685L publication Critical patent/NO961685L/no
Publication of NO961685D0 publication Critical patent/NO961685D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO961685A 1992-02-06 1996-04-26 Fremgangsmåte for behandling av hepatitt-B-bærere med minimal sykdom NO961685D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/833,468 US5308833A (en) 1992-02-06 1992-02-06 Method for treating hepatitis B carriers with minimal disease
PCT/US1993/010343 WO1995011688A1 (en) 1992-02-06 1993-10-28 Method for treating hepatitis b carriers with minimal disease

Publications (2)

Publication Number Publication Date
NO961685L NO961685L (no) 1996-04-26
NO961685D0 true NO961685D0 (no) 1996-04-26

Family

ID=1340654

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961685A NO961685D0 (no) 1992-02-06 1996-04-26 Fremgangsmåte for behandling av hepatitt-B-bærere med minimal sykdom

Country Status (5)

Country Link
EP (1) EP0728010A4 (no)
NO (1) NO961685D0 (no)
SG (1) SG64892A1 (no)
TW (1) TW249755B (no)
WO (1) WO1995011688A1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0731710T3 (da) * 1993-11-05 2003-06-16 Sciclone Pharmaceuticals Inc Fremgangsmåde og præparat til behandling af patienter med inkompenseret leversygdom

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
TW224053B (no) * 1991-09-13 1994-05-21 Paul B Chretien
US5308833A (en) * 1992-02-06 1994-05-03 Sciclone Pharmaceuticals Method for treating hepatitis B carriers with minimal disease

Also Published As

Publication number Publication date
TW249755B (no) 1995-06-21
EP0728010A4 (en) 1997-10-01
SG64892A1 (en) 1999-05-25
EP0728010A1 (en) 1996-08-28
NO961685L (no) 1996-04-26
WO1995011688A1 (en) 1995-05-04

Similar Documents

Publication Publication Date Title
FI941133L (fi) Koostumus ja menetelmä hepatiitti C:n hoitamiseksi
FI935861L (fi) Artikelbaerare av haollartyp
BR9202222A (pt) Processo de hidroformilacao e composto de bisfosfito
NO179531C (no) Fremgangsmåte for brönnbehandling
NO924461D0 (no) Dipyridamol for behandling av proliferaktive sykdommer
NO951370D0 (no) Fremgangsmåte ved fremstilling av medikamentpelleter
FI951596L (fi) Menetelmä 10-desasetyylibakkatiini-III:n saamiseksi
FI934686L (fi) En process foer beklaednad av oorganiska partiklar
BR9305918A (pt) Processo de preparação de 6-aminocapronitrila
DK39592D0 (da) Method of detecting microorganisms
NO972402D0 (no) Fremgangsmåte for fremstilling av bærere
EP0585549A3 (en) Method for producing ectoprotein of hepatitis c virus
DK329887D0 (da) Fremgangsmaade til behandling af asbest
EP0627930A4 (en) COMPOSITION AND METHOD FOR TREATING HEPATITIS B.
FI941705A0 (fi) Menetelmä viruspatogeenien läpipääsyn estämiseksi
DK96392D0 (da) Modifikationsmetode
EP0472595A4 (en) Method of treatment of hepatitis
NO961685D0 (no) Fremgangsmåte for behandling av hepatitt-B-bærere med minimal sykdom
NO940171L (no) Fremgangsmåte for kontinuerlig fremstilling av dimetoksyetanal
LV10119A (lv) Lizocima dimeru iegusanas metode
DE69310997D1 (de) Prillverfahren
EP0472663A4 (en) Method of treatment of hepatitis
CS224391A3 (en) Method of treating allergic conjunctivitis
ZA938110B (en) Treatment of hepatitis B carriers with minimal disease
ZW11693A1 (en) Method of treating viral infections